Impact of tumor necrosis factor antagonist combination and anti-integrin therapies on body mass index in inflammatory bowel disease: A cross-sectional study.

Front Med (Lausanne) · 2022 · PMC9853179 · PMID 36687448

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Moreover, records of the weight distribution among IBD patients suggest a clear trend of increased obesity impacting patients with CD rather than UC ( 4 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.